Lack of genetic screening for cancers

In a new study published Monday in the journal Cancer, it was noted that while genetic testing to check if a woman has the BRCA1 or BRCA2 mutations can be a useful tool for preventing breast cancer and ovarian cancer in some cases, many doctors are not referring patients.

Researchers at the Centers for Disease Control and Prevention in Atlanta sent out a survey to 3,200 family and internal medicine practitioners and obstetrician/gynecologists across the U.S.  They found that physicians may not recommend screening often enough in women at high risk for breast and ovarian cancers (who, guidelines stipulate, generally should be offered such services) and that doctors may recommend screening too often for women at average risk of the diseases (for whom the potential harm of undergoing screening may likely outweigh benefits).

Just 41% said they would recommend referral for genetic counseling for a woman at high risk for the cancers, based on family and personal history. Twenty-nine percent said they would recommend the counseling for a woman at average risk.

Doctors were more likely to adhere to guidelines when examining a 35-year-old than a 51-year-old, the researchers found. Female physicians made the right recommendation more than males; OB/GYNs did a better job than internists and family physicians.  Urban doctors were more likely to comply with guidelines than rural doctors.

The authors recommended the development of easy-to-use tools and further education about genetic testing to help doctors assess patients' risk and make appropriate recommendations.

Dr. Katrina Trivers, the study's lead author and an epidemiologist at the CDC, said the study was not meant to be alarmist. She said, “[The 41 percent] does seem low to me but this is not a particularly straightforward study. Guidelines are complicated. It's difficult to know what makes a woman high risk. Guidelines differ on what is considered high risk.”

Dr. Virginia Kaklamani, an associate professor at Northwestern University and co-director of the Cancer Genetics Program, said that while there was no harm in a woman receiving genetic counseling, testing could be harmful because unnecessary test could just lead to increased anxieties in a patient.
Trivers said the study's results also highlighted the medical community's need to support primary-care physicians more in their understanding of risk assessment. She said tools need to be developed to educate doctors about how to assess risk accurately as well.

Beth N. Peshkin, a senior genetic counselor at Georgetown Lombardi Cancer Center, said it was reasonable to believe that doctors should adapt. “These [BRCA] genes were identified in 1994 and 1995 and guidelines have been around for years,” she said. “This study is a wakeup call to get the message out and educate physicians so they have in their arsenal the knowledge and confidence” to assess risk.

At the end of the day, you have to be your very own advocate,” Trivers said.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Lack of genetic screening for cancers. News-Medical. Retrieved on October 26, 2020 from

  • MLA

    Mandal, Ananya. "Lack of genetic screening for cancers". News-Medical. 26 October 2020. <>.

  • Chicago

    Mandal, Ananya. "Lack of genetic screening for cancers". News-Medical. (accessed October 26, 2020).

  • Harvard

    Mandal, Ananya. 2018. Lack of genetic screening for cancers. News-Medical, viewed 26 October 2020,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
A comprehensive clinical and genetic model for predicting severe COVID-19 risk